About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 349 record(s)
Req # A-2020-09098
Copies of all records discussing the impacts of the regulatory changes to the PMPRB from August 2019 until August 2020. Copies of all correspondence from all pharmaceutical companies expressing their concerns with the changes and any responses back to these companies. Copies of all correspondence from all advocating groups expressing concerns with the changes and any responses back to these groups. Copies of all correspondence between departmental staff discussing the impacts of the regulatory changes to the PMPRB. Copies of all records discussing the impacts of the PMPRB changes on individuals living with rare diseases. Copies of all correspondence from Vertex Pharmaceuticals relating to Kalydeco, Orkambi, Symdeko, and Trikafta. Copies of all correspondence between government officials (Prime Minister, Ministers, all members of parliament, constituency staff, deputies, assistant deputies, directors, managers, supervisors, staff, and any other employee of the Government of Canada relating to the PMPRB regulatory changes. Copies of all presentations relating to the PMPRB regulatory changes.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-0018
Records regarding this article in The Logic/business relations between CIHR and Palantir.Organization: Canadian Institutes of Health Research
August 2020
Req # A-2020-0010
Records held by CIHR pertaining to all funding competitions and corresponding grants, awards, and contracts allocated by CIHR between January 1, 2020 and May 3, 2020Organization: Canadian Institutes of Health Research
August 2020
Req # A-2020-0013
Information pertaining to grant MOP-119527Organization: Canadian Institutes of Health Research
August 2020
Req # A-2020-0015
21380817 Briefing note to the President: Directed Grant - Funding to support the Canadian Treatments for COVID (CATCO) Trial 2020-0050 Briefing note to the President: Approval to Launch COVID-19 Rapid Response Funding Opportunity 21314605 Briefing note to the President: Approval to mobilize staff for preparation of a second phase rapid response 21270784 Briefing note to the President: Impacts of COVID-19 situation on CIHR’s 2019-20 audited financial statements 21242288 Briefing note to the President: Evaluation of the pandemic preparedness strategic research initiative: Lessons learnedOrganization: Canadian Institutes of Health Research
August 2020
Req # A-2020-01436
Copies of reports, discussions, briefings, memos and decisions related to the introductory price review for erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
August 2020
Req # A-2020-04137
Copies of the PMPRB documentation related to the scientific review and pricing review of erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
August 2020
Nothing to report this month
Organization: Canadian Institutes of Health Research
Req # A-2020-0008
Data necessary for performing a correlation analysis between treatment success rate & various predictors such as program geo-location, program types, specific protocol implementations, funding per program, addiction rates, etc. This data may be available through CRISM or similar programs. The preferred date ranges are from as recent as possible to as far back as possible.Organization: Canadian Institutes of Health Research
June 2020
Req # A-2020-0014
Briefing note to the President: Evaluation of the pandemic preparedness strategic research initiative: Lessons learned.Organization: Canadian Institutes of Health Research
June 2020